Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Breast Neoplasms | 118 | 2024 | 20822 | 5.140 |
Why?
|
Genetic Heterogeneity | 10 | 2020 | 733 | 2.870 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 15 | 2023 | 949 | 2.660 |
Why?
|
Carcinoma, Ductal, Breast | 16 | 2023 | 1101 | 2.640 |
Why?
|
Mammary Glands, Human | 14 | 2019 | 199 | 2.260 |
Why?
|
Neoplasms | 50 | 2023 | 21683 | 2.150 |
Why?
|
Drug Resistance, Neoplasm | 15 | 2021 | 5172 | 2.050 |
Why?
|
Mammary Glands, Animal | 10 | 2019 | 276 | 1.850 |
Why?
|
Epithelial Cells | 30 | 2021 | 3690 | 1.790 |
Why?
|
Inflammatory Breast Neoplasms | 3 | 2024 | 143 | 1.790 |
Why?
|
Neoplastic Stem Cells | 16 | 2014 | 1376 | 1.770 |
Why?
|
Breast | 20 | 2023 | 1969 | 1.740 |
Why?
|
Gene Expression Regulation, Neoplastic | 42 | 2023 | 8428 | 1.660 |
Why?
|
Gene Expression Profiling | 37 | 2019 | 9438 | 1.650 |
Why?
|
Epigenesis, Genetic | 24 | 2022 | 3647 | 1.600 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 9 | 2019 | 323 | 1.410 |
Why?
|
Neoplasm Metastasis | 14 | 2019 | 4851 | 1.370 |
Why?
|
Tumor Microenvironment | 13 | 2021 | 3586 | 1.370 |
Why?
|
Mutation | 36 | 2021 | 29786 | 1.160 |
Why?
|
Jumonji Domain-Containing Histone Demethylases | 3 | 2018 | 182 | 1.160 |
Why?
|
Nuclear Proteins | 15 | 2023 | 5853 | 1.160 |
Why?
|
DNA Methylation | 16 | 2015 | 4286 | 1.080 |
Why?
|
Clone Cells | 6 | 2020 | 1692 | 1.070 |
Why?
|
DNA, Neoplasm | 9 | 2020 | 1758 | 1.020 |
Why?
|
Cell Line, Tumor | 40 | 2023 | 16689 | 1.010 |
Why?
|
Tumor Suppressor Proteins | 17 | 2019 | 2849 | 1.000 |
Why?
|
Receptor, erbB-2 | 10 | 2024 | 2416 | 0.950 |
Why?
|
Paclitaxel | 4 | 2024 | 1708 | 0.930 |
Why?
|
Stem Cells | 11 | 2023 | 3567 | 0.930 |
Why?
|
Cell Transformation, Neoplastic | 19 | 2018 | 2942 | 0.920 |
Why?
|
BRCA1 Protein | 5 | 2019 | 1149 | 0.880 |
Why?
|
Transcription Factors | 15 | 2023 | 12208 | 0.870 |
Why?
|
Neoplasm Proteins | 18 | 2020 | 3703 | 0.850 |
Why?
|
Cell Lineage | 6 | 2018 | 2504 | 0.840 |
Why?
|
Tumor Escape | 2 | 2021 | 349 | 0.810 |
Why?
|
Repressor Proteins | 6 | 2018 | 3023 | 0.790 |
Why?
|
Stromal Cells | 11 | 2013 | 1355 | 0.790 |
Why?
|
Models, Biological | 18 | 2021 | 9583 | 0.790 |
Why?
|
Carcinoma in Situ | 9 | 2010 | 806 | 0.790 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 5 | 2021 | 890 | 0.780 |
Why?
|
Azepines | 3 | 2020 | 336 | 0.770 |
Why?
|
Carcinoma, Ductal | 4 | 2010 | 101 | 0.760 |
Why?
|
Oncogenes | 6 | 2014 | 1265 | 0.750 |
Why?
|
Cyclin-Dependent Kinase 6 | 3 | 2020 | 322 | 0.740 |
Why?
|
Disease Progression | 28 | 2023 | 13284 | 0.740 |
Why?
|
Phosphatidylinositol 3-Kinases | 10 | 2024 | 2938 | 0.740 |
Why?
|
Humans | 202 | 2024 | 744343 | 0.720 |
Why?
|
Female | 131 | 2024 | 380194 | 0.710 |
Why?
|
Genes, Tumor Suppressor | 13 | 2008 | 1097 | 0.710 |
Why?
|
Genes, erbB-2 | 3 | 2015 | 162 | 0.710 |
Why?
|
Retinoblastoma-Binding Protein 2 | 1 | 2018 | 31 | 0.670 |
Why?
|
Neoplasm Invasiveness | 18 | 2017 | 3616 | 0.670 |
Why?
|
Nitriles | 1 | 2024 | 956 | 0.660 |
Why?
|
Estrogen Receptor alpha | 4 | 2019 | 577 | 0.640 |
Why?
|
Genetic Variation | 5 | 2017 | 6544 | 0.640 |
Why?
|
Cyclin-Dependent Kinase 4 | 5 | 2020 | 538 | 0.640 |
Why?
|
Animals | 77 | 2023 | 168757 | 0.610 |
Why?
|
Triazoles | 3 | 2020 | 911 | 0.600 |
Why?
|
Xenograft Model Antitumor Assays | 9 | 2019 | 3557 | 0.600 |
Why?
|
Fibroblasts | 9 | 2021 | 4161 | 0.600 |
Why?
|
Cyclins | 16 | 2004 | 603 | 0.600 |
Why?
|
Single-Cell Analysis | 4 | 2019 | 2183 | 0.590 |
Why?
|
Proteins | 6 | 2020 | 6103 | 0.580 |
Why?
|
Immunotherapy | 6 | 2023 | 4445 | 0.580 |
Why?
|
Signal Transduction | 29 | 2023 | 23403 | 0.570 |
Why?
|
BRCA2 Protein | 2 | 2019 | 794 | 0.570 |
Why?
|
Homeodomain Proteins | 4 | 2023 | 2421 | 0.560 |
Why?
|
Estrogens | 6 | 2023 | 1566 | 0.540 |
Why?
|
Oligonucleotide Array Sequence Analysis | 11 | 2013 | 3920 | 0.530 |
Why?
|
Cell Differentiation | 16 | 2019 | 11483 | 0.530 |
Why?
|
Cell Proliferation | 20 | 2020 | 10481 | 0.520 |
Why?
|
Pyrazoles | 2 | 2024 | 1972 | 0.510 |
Why?
|
RNA, Neoplasm | 5 | 2013 | 769 | 0.490 |
Why?
|
Calcium-Binding Proteins | 5 | 2008 | 1081 | 0.490 |
Why?
|
Tumor Suppressor Protein p53 | 8 | 2012 | 2948 | 0.480 |
Why?
|
Wnt1 Protein | 1 | 2014 | 118 | 0.480 |
Why?
|
Cyclin-Dependent Kinases | 11 | 1996 | 671 | 0.460 |
Why?
|
STAT3 Transcription Factor | 2 | 2023 | 873 | 0.450 |
Why?
|
Mice | 42 | 2023 | 81183 | 0.440 |
Why?
|
Cytokines | 7 | 2005 | 7322 | 0.430 |
Why?
|
Transforming Growth Factor beta | 9 | 2014 | 2007 | 0.430 |
Why?
|
Phenotype | 18 | 2020 | 16365 | 0.420 |
Why?
|
Cell Cycle | 14 | 2017 | 2967 | 0.410 |
Why?
|
Pyrimidines | 1 | 2024 | 2942 | 0.400 |
Why?
|
Rats, Inbred ACI | 2 | 2022 | 44 | 0.400 |
Why?
|
Histones | 6 | 2017 | 2599 | 0.400 |
Why?
|
Cell Cycle Proteins | 10 | 2022 | 3462 | 0.400 |
Why?
|
Gene Library | 10 | 2010 | 1074 | 0.390 |
Why?
|
Genome, Human | 8 | 2016 | 4420 | 0.390 |
Why?
|
Apoptosis | 10 | 2018 | 9727 | 0.380 |
Why?
|
Tumor Cells, Cultured | 18 | 2013 | 6314 | 0.380 |
Why?
|
Gene Amplification | 3 | 2014 | 1063 | 0.380 |
Why?
|
Microchemistry | 1 | 2010 | 57 | 0.380 |
Why?
|
Genomics | 6 | 2020 | 5720 | 0.370 |
Why?
|
Alternative Splicing | 2 | 2015 | 1117 | 0.370 |
Why?
|
RNA, Antisense | 1 | 2010 | 138 | 0.370 |
Why?
|
CDC2-CDC28 Kinases | 6 | 1995 | 113 | 0.360 |
Why?
|
Parity | 1 | 2013 | 929 | 0.360 |
Why?
|
Plasma | 1 | 2013 | 575 | 0.350 |
Why?
|
Transcription, Genetic | 6 | 2018 | 7722 | 0.350 |
Why?
|
Molecular Targeted Therapy | 3 | 2019 | 2727 | 0.350 |
Why?
|
Genes, BRCA1 | 4 | 2014 | 781 | 0.340 |
Why?
|
Cyclooxygenase 2 | 2 | 2009 | 611 | 0.340 |
Why?
|
Chemokines, CXC | 2 | 2008 | 422 | 0.340 |
Why?
|
Gene Expression | 11 | 2017 | 7799 | 0.340 |
Why?
|
Patient Selection | 2 | 2019 | 4215 | 0.340 |
Why?
|
Selection, Genetic | 1 | 2014 | 914 | 0.340 |
Why?
|
Antineoplastic Agents | 9 | 2020 | 13695 | 0.330 |
Why?
|
Adult Stem Cells | 3 | 2011 | 216 | 0.330 |
Why?
|
Protein-Tyrosine Kinases | 3 | 2015 | 2455 | 0.330 |
Why?
|
Protein Structure, Tertiary | 1 | 2016 | 3846 | 0.320 |
Why?
|
Cell Communication | 6 | 2019 | 1621 | 0.320 |
Why?
|
Karyotyping | 3 | 2013 | 1243 | 0.310 |
Why?
|
Janus Kinase 2 | 1 | 2011 | 528 | 0.310 |
Why?
|
Tamoxifen | 5 | 2015 | 981 | 0.310 |
Why?
|
Promoter Regions, Genetic | 6 | 2015 | 5867 | 0.300 |
Why?
|
Cathepsins | 1 | 2008 | 241 | 0.300 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2012 | 635 | 0.300 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2010 | 520 | 0.300 |
Why?
|
Macrophages | 2 | 2021 | 5655 | 0.290 |
Why?
|
Cell Shape | 3 | 2015 | 375 | 0.290 |
Why?
|
Epithelium | 8 | 2013 | 1679 | 0.290 |
Why?
|
Neutrophils | 1 | 2019 | 3719 | 0.290 |
Why?
|
Multiple Endocrine Neoplasia Type 1 | 1 | 2006 | 46 | 0.280 |
Why?
|
Genes, Neoplasm | 3 | 2010 | 376 | 0.280 |
Why?
|
Mesoderm | 2 | 2009 | 686 | 0.280 |
Why?
|
Proto-Oncogene Proteins c-akt | 5 | 2013 | 2503 | 0.280 |
Why?
|
PTEN Phosphohydrolase | 1 | 2012 | 1142 | 0.270 |
Why?
|
Rats, Sprague-Dawley | 3 | 2022 | 8301 | 0.270 |
Why?
|
Mammary Neoplasms, Animal | 1 | 2007 | 137 | 0.270 |
Why?
|
Neoplasm Transplantation | 4 | 2021 | 2085 | 0.270 |
Why?
|
Carcinoma | 5 | 2022 | 2375 | 0.270 |
Why?
|
S100 Proteins | 6 | 2012 | 259 | 0.270 |
Why?
|
Genes, p53 | 3 | 2013 | 755 | 0.260 |
Why?
|
Genetic Predisposition to Disease | 7 | 2019 | 17446 | 0.250 |
Why?
|
Extracellular Matrix | 2 | 2010 | 1741 | 0.250 |
Why?
|
RNA, Small Interfering | 5 | 2018 | 3505 | 0.250 |
Why?
|
Colorectal Neoplasms | 9 | 2013 | 6773 | 0.250 |
Why?
|
DNA Damage | 5 | 2022 | 2432 | 0.250 |
Why?
|
Carcinoma, Lobular | 3 | 2008 | 484 | 0.250 |
Why?
|
Receptors, Estrogen | 6 | 2019 | 2187 | 0.240 |
Why?
|
Microtubule-Associated Proteins | 6 | 1996 | 1086 | 0.240 |
Why?
|
DNA-Binding Proteins | 3 | 2018 | 9648 | 0.240 |
Why?
|
Neoplastic Processes | 1 | 2023 | 35 | 0.240 |
Why?
|
Fluorescent Antibody Technique | 4 | 2019 | 2505 | 0.240 |
Why?
|
Sequence Analysis, DNA | 5 | 2010 | 4803 | 0.240 |
Why?
|
Genes, BRCA2 | 2 | 2004 | 618 | 0.230 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2023 | 2540 | 0.230 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 9 | 2013 | 4751 | 0.230 |
Why?
|
Cell Division | 5 | 2004 | 4568 | 0.230 |
Why?
|
G1 Phase | 5 | 1996 | 415 | 0.220 |
Why?
|
Antigens, CD | 3 | 2010 | 4026 | 0.220 |
Why?
|
Biomedical Research | 3 | 2016 | 3309 | 0.220 |
Why?
|
In Situ Hybridization, Fluorescence | 6 | 2015 | 2649 | 0.220 |
Why?
|
Cell Movement | 8 | 2017 | 5217 | 0.220 |
Why?
|
Chromatin | 4 | 2019 | 2934 | 0.210 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2018 | 4034 | 0.210 |
Why?
|
Rats | 4 | 2022 | 24260 | 0.210 |
Why?
|
Chromosome Aberrations | 2 | 2010 | 1813 | 0.210 |
Why?
|
Neoadjuvant Therapy | 3 | 2024 | 2728 | 0.210 |
Why?
|
Prognosis | 10 | 2019 | 29063 | 0.210 |
Why?
|
Pluripotent Stem Cells | 1 | 2009 | 795 | 0.200 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 3 | 2022 | 170 | 0.200 |
Why?
|
Histone Acetyltransferases | 1 | 2023 | 336 | 0.200 |
Why?
|
Enzyme Activation | 9 | 2015 | 3701 | 0.200 |
Why?
|
Estrogen Antagonists | 1 | 2002 | 152 | 0.200 |
Why?
|
Embryonic Stem Cells | 1 | 2009 | 1294 | 0.200 |
Why?
|
Cell Fusion | 3 | 2015 | 297 | 0.200 |
Why?
|
Cell Growth Processes | 3 | 2014 | 399 | 0.200 |
Why?
|
Arylsulfotransferase | 1 | 2000 | 28 | 0.200 |
Why?
|
Melanoma | 1 | 2019 | 5510 | 0.190 |
Why?
|
Hormones | 2 | 2022 | 889 | 0.180 |
Why?
|
Epigenomics | 3 | 2015 | 903 | 0.180 |
Why?
|
RNA, Messenger | 12 | 2024 | 13033 | 0.180 |
Why?
|
Sequence Homology, Amino Acid | 5 | 2003 | 2839 | 0.180 |
Why?
|
Interleukin-6 | 3 | 2024 | 3200 | 0.180 |
Why?
|
Gene Expression Regulation | 5 | 2015 | 12072 | 0.180 |
Why?
|
Pregnancy | 7 | 2019 | 29144 | 0.180 |
Why?
|
Molecular Sequence Data | 14 | 2015 | 18111 | 0.180 |
Why?
|
T-Lymphocytes | 3 | 2017 | 10180 | 0.180 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2023 | 805 | 0.180 |
Why?
|
Ploidies | 1 | 2020 | 281 | 0.180 |
Why?
|
Mesenchymal Stem Cells | 3 | 2019 | 1632 | 0.180 |
Why?
|
Endocrine Cells | 1 | 2019 | 10 | 0.170 |
Why?
|
T Cell Transcription Factor 1 | 1 | 2019 | 49 | 0.170 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2015 | 713 | 0.170 |
Why?
|
Osteoprotegerin | 1 | 2020 | 176 | 0.170 |
Why?
|
Integrin alpha1 | 1 | 2019 | 13 | 0.170 |
Why?
|
Inflammation | 1 | 2019 | 10638 | 0.170 |
Why?
|
Transfection | 7 | 2017 | 5892 | 0.170 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2002 | 241 | 0.170 |
Why?
|
Transcriptional Activation | 3 | 2022 | 1783 | 0.170 |
Why?
|
Neovascularization, Pathologic | 3 | 2008 | 2635 | 0.170 |
Why?
|
Evolution, Molecular | 4 | 2014 | 1940 | 0.170 |
Why?
|
Cell Survival | 6 | 2018 | 5882 | 0.170 |
Why?
|
Disease Models, Animal | 11 | 2023 | 18029 | 0.170 |
Why?
|
Cells, Cultured | 10 | 2018 | 19229 | 0.170 |
Why?
|
Estrogen Receptor Modulators | 1 | 2018 | 61 | 0.170 |
Why?
|
Receptors, Progesterone | 2 | 2019 | 1097 | 0.160 |
Why?
|
Co-Repressor Proteins | 1 | 2019 | 194 | 0.160 |
Why?
|
Mice, Inbred NOD | 3 | 2020 | 1878 | 0.160 |
Why?
|
Reactive Oxygen Species | 7 | 2017 | 2077 | 0.160 |
Why?
|
Vesicular Transport Proteins | 1 | 2021 | 377 | 0.160 |
Why?
|
Telomere | 1 | 2004 | 910 | 0.160 |
Why?
|
Cystatin A | 1 | 2017 | 5 | 0.160 |
Why?
|
Brain Neoplasms | 2 | 2019 | 8863 | 0.160 |
Why?
|
Genetic Markers | 2 | 2013 | 2634 | 0.160 |
Why?
|
Keratinocytes | 3 | 2013 | 798 | 0.160 |
Why?
|
Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2018 | 113 | 0.160 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2024 | 11524 | 0.160 |
Why?
|
Protein Binding | 6 | 2018 | 9386 | 0.160 |
Why?
|
Carrier Proteins | 5 | 2013 | 5021 | 0.150 |
Why?
|
Biological Evolution | 2 | 2017 | 1076 | 0.150 |
Why?
|
Germ-Line Mutation | 3 | 2019 | 1788 | 0.150 |
Why?
|
Cyclin D3 | 1 | 2017 | 55 | 0.150 |
Why?
|
Drug Design | 3 | 2011 | 1076 | 0.150 |
Why?
|
Organ Specificity | 3 | 2015 | 2008 | 0.150 |
Why?
|
Up-Regulation | 3 | 2020 | 4217 | 0.150 |
Why?
|
Cyclin G1 | 1 | 2017 | 17 | 0.150 |
Why?
|
Cluster Analysis | 6 | 2015 | 2715 | 0.150 |
Why?
|
DNA, Mitochondrial | 3 | 2017 | 817 | 0.150 |
Why?
|
Amino Acid Sequence | 8 | 2003 | 13815 | 0.140 |
Why?
|
Retinoblastoma Protein | 2 | 2020 | 704 | 0.140 |
Why?
|
Cell Line | 14 | 2016 | 15997 | 0.140 |
Why?
|
Lung Neoplasms | 4 | 2019 | 13102 | 0.140 |
Why?
|
Antigens, Neoplasm | 3 | 2019 | 1988 | 0.140 |
Why?
|
MicroRNAs | 4 | 2017 | 3752 | 0.140 |
Why?
|
Gene Dosage | 2 | 2018 | 1252 | 0.140 |
Why?
|
Centrosome | 2 | 2014 | 201 | 0.140 |
Why?
|
Mediator Complex Subunit 1 | 1 | 2016 | 29 | 0.140 |
Why?
|
Procollagen-Proline Dioxygenase | 2 | 2009 | 86 | 0.140 |
Why?
|
DNA Copy Number Variations | 2 | 2023 | 1941 | 0.140 |
Why?
|
Flow Cytometry | 4 | 2017 | 5974 | 0.140 |
Why?
|
Fungal Proteins | 3 | 1994 | 912 | 0.140 |
Why?
|
Loss of Heterozygosity | 2 | 2008 | 684 | 0.140 |
Why?
|
Drug Synergism | 1 | 2020 | 1792 | 0.130 |
Why?
|
Fanconi Anemia Complementation Group D2 Protein | 1 | 2016 | 148 | 0.130 |
Why?
|
Dermcidins | 1 | 2015 | 1 | 0.130 |
Why?
|
Phosphoserine | 1 | 2016 | 206 | 0.130 |
Why?
|
Mitogens | 2 | 1995 | 232 | 0.130 |
Why?
|
Blotting, Northern | 3 | 2002 | 1581 | 0.130 |
Why?
|
Casein Kinase II | 1 | 2016 | 128 | 0.130 |
Why?
|
Blotting, Western | 5 | 2013 | 5179 | 0.130 |
Why?
|
Down-Regulation | 7 | 2009 | 3002 | 0.130 |
Why?
|
Immune System | 1 | 2020 | 805 | 0.130 |
Why?
|
Immunohistochemistry | 6 | 2019 | 11366 | 0.130 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2018 | 3617 | 0.130 |
Why?
|
Proto-Oncogene Proteins | 6 | 2006 | 4554 | 0.130 |
Why?
|
NF-kappa B | 4 | 2012 | 2499 | 0.130 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2020 | 736 | 0.130 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2017 | 255 | 0.120 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2005 | 3508 | 0.120 |
Why?
|
Interleukin-11 | 1 | 2014 | 63 | 0.120 |
Why?
|
Progesterone | 1 | 2019 | 776 | 0.120 |
Why?
|
Forkhead Transcription Factors | 2 | 2014 | 1613 | 0.120 |
Why?
|
Binding, Competitive | 1 | 2016 | 1157 | 0.120 |
Why?
|
RNA Editing | 1 | 2015 | 148 | 0.120 |
Why?
|
Lung | 3 | 2019 | 9856 | 0.120 |
Why?
|
Protein Phosphatase 2 | 1 | 2016 | 229 | 0.120 |
Why?
|
Animals, Genetically Modified | 1 | 2019 | 1549 | 0.120 |
Why?
|
Forecasting | 2 | 2016 | 2951 | 0.120 |
Why?
|
Genetic Testing | 3 | 2016 | 3444 | 0.120 |
Why?
|
Biotechnology | 1 | 2016 | 281 | 0.120 |
Why?
|
Amino Acid Transport System y+ | 1 | 2013 | 35 | 0.120 |
Why?
|
Selective Estrogen Receptor Modulators | 1 | 2014 | 129 | 0.110 |
Why?
|
Adenosine Deaminase | 1 | 2015 | 241 | 0.110 |
Why?
|
Papillomavirus E7 Proteins | 1 | 2013 | 123 | 0.110 |
Why?
|
Phosphorylation | 8 | 2017 | 8436 | 0.110 |
Why?
|
ras GTPase-Activating Proteins | 1 | 2013 | 101 | 0.110 |
Why?
|
Sexual Maturation | 1 | 2015 | 265 | 0.110 |
Why?
|
Mice, Nude | 3 | 2011 | 3689 | 0.110 |
Why?
|
Immunologic Factors | 1 | 2022 | 1580 | 0.110 |
Why?
|
Haploinsufficiency | 1 | 2014 | 328 | 0.110 |
Why?
|
DNA Repair | 4 | 2022 | 2046 | 0.110 |
Why?
|
Methods | 2 | 2010 | 1129 | 0.110 |
Why?
|
Organogenesis | 1 | 2014 | 222 | 0.110 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 7 | 2000 | 365 | 0.110 |
Why?
|
Precancerous Conditions | 2 | 2017 | 975 | 0.110 |
Why?
|
Exons | 3 | 2011 | 2437 | 0.110 |
Why?
|
Immunoenzyme Techniques | 2 | 2013 | 1799 | 0.110 |
Why?
|
Sequence Analysis, RNA | 2 | 2018 | 2012 | 0.110 |
Why?
|
Protein Kinases | 3 | 1994 | 1640 | 0.110 |
Why?
|
Chromatin Immunoprecipitation | 2 | 2015 | 893 | 0.100 |
Why?
|
Databases, Genetic | 3 | 2010 | 1783 | 0.100 |
Why?
|
Societies, Scientific | 1 | 2012 | 220 | 0.100 |
Why?
|
Oncogene Proteins, Viral | 1 | 2013 | 362 | 0.100 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2015 | 692 | 0.100 |
Why?
|
Bacteria | 1 | 2022 | 2114 | 0.100 |
Why?
|
Estradiol | 1 | 2018 | 2020 | 0.100 |
Why?
|
p21-Activated Kinases | 1 | 2011 | 128 | 0.100 |
Why?
|
Transplantation, Heterologous | 4 | 2013 | 2382 | 0.100 |
Why?
|
Research | 1 | 2020 | 1999 | 0.100 |
Why?
|
Ki-67 Antigen | 2 | 2008 | 644 | 0.100 |
Why?
|
Base Sequence | 8 | 2015 | 12797 | 0.100 |
Why?
|
Receptor, erbB-3 | 1 | 2011 | 142 | 0.100 |
Why?
|
Treatment Outcome | 4 | 2024 | 63114 | 0.100 |
Why?
|
DNA Helicases | 1 | 2016 | 859 | 0.090 |
Why?
|
Glutamine | 1 | 2013 | 578 | 0.090 |
Why?
|
Antigens, Surface | 1 | 2015 | 1663 | 0.090 |
Why?
|
Cell Dedifferentiation | 1 | 2011 | 135 | 0.090 |
Why?
|
Paracrine Communication | 2 | 2008 | 277 | 0.090 |
Why?
|
Isoenzymes | 2 | 2010 | 1726 | 0.090 |
Why?
|
Protein Kinase Inhibitors | 5 | 2013 | 5535 | 0.090 |
Why?
|
Doxorubicin | 2 | 2015 | 2234 | 0.090 |
Why?
|
Retinal Dehydrogenase | 1 | 2010 | 74 | 0.090 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2023 | 4479 | 0.090 |
Why?
|
Chromosomes, Human, Pair 12 | 2 | 2006 | 462 | 0.090 |
Why?
|
Immunophenotyping | 1 | 2015 | 1880 | 0.090 |
Why?
|
Polymorphism, Genetic | 1 | 2000 | 4328 | 0.090 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2011 | 1285 | 0.090 |
Why?
|
Cyclin-Dependent Kinase 2 | 6 | 1995 | 191 | 0.090 |
Why?
|
Piperazines | 1 | 2020 | 2488 | 0.090 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2011 | 15519 | 0.090 |
Why?
|
Aldehyde Dehydrogenase | 1 | 2010 | 142 | 0.090 |
Why?
|
HEK293 Cells | 1 | 2018 | 4204 | 0.090 |
Why?
|
Matrix Metalloproteinases | 1 | 2011 | 391 | 0.080 |
Why?
|
Genes, jun | 1 | 2008 | 71 | 0.080 |
Why?
|
Risk Factors | 7 | 2023 | 72290 | 0.080 |
Why?
|
RNA | 4 | 2024 | 2749 | 0.080 |
Why?
|
Basement Membrane | 1 | 2010 | 356 | 0.080 |
Why?
|
Cathepsin K | 1 | 2008 | 68 | 0.080 |
Why?
|
Keratins | 1 | 2010 | 515 | 0.080 |
Why?
|
Advisory Committees | 1 | 2012 | 775 | 0.080 |
Why?
|
Pyridines | 1 | 2020 | 2825 | 0.080 |
Why?
|
Enhancer Elements, Genetic | 1 | 2015 | 1341 | 0.080 |
Why?
|
Receptors, IgE | 1 | 2010 | 389 | 0.080 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2010 | 460 | 0.080 |
Why?
|
Expressed Sequence Tags | 2 | 2006 | 255 | 0.080 |
Why?
|
Mink | 4 | 1995 | 44 | 0.080 |
Why?
|
Protein Isoforms | 1 | 2013 | 1730 | 0.080 |
Why?
|
DNA Replication | 1 | 2014 | 1399 | 0.080 |
Why?
|
Cyclin D1 | 1 | 2009 | 463 | 0.080 |
Why?
|
Pyrroles | 1 | 2014 | 1146 | 0.080 |
Why?
|
Lymphatic Metastasis | 2 | 2014 | 2924 | 0.080 |
Why?
|
MAP Kinase Signaling System | 2 | 2011 | 1526 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2011 | 578 | 0.080 |
Why?
|
Psoriasis | 2 | 2008 | 898 | 0.080 |
Why?
|
Nanoparticles | 2 | 2017 | 1905 | 0.070 |
Why?
|
Hyperplasia | 3 | 2002 | 1185 | 0.070 |
Why?
|
Proteomics | 2 | 2016 | 3638 | 0.070 |
Why?
|
Immunity, Innate | 1 | 2019 | 2958 | 0.070 |
Why?
|
Receptors, Notch | 1 | 2012 | 739 | 0.070 |
Why?
|
Hedgehog Proteins | 1 | 2012 | 783 | 0.070 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2015 | 1524 | 0.070 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2009 | 320 | 0.070 |
Why?
|
Aneuploidy | 2 | 2014 | 530 | 0.070 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2024 | 9239 | 0.070 |
Why?
|
Aged | 8 | 2023 | 163280 | 0.070 |
Why?
|
Reproducibility of Results | 7 | 2024 | 19905 | 0.070 |
Why?
|
Translocation, Genetic | 1 | 2012 | 1420 | 0.070 |
Why?
|
Immunoblotting | 3 | 2009 | 1682 | 0.070 |
Why?
|
Barrett Esophagus | 1 | 2010 | 494 | 0.070 |
Why?
|
Receptors, Retinoic Acid | 2 | 2004 | 232 | 0.070 |
Why?
|
RNA-Binding Proteins | 1 | 2015 | 1903 | 0.070 |
Why?
|
Genome-Wide Association Study | 4 | 2017 | 12261 | 0.070 |
Why?
|
I-kappa B Kinase | 1 | 2007 | 252 | 0.070 |
Why?
|
Gene Knockout Techniques | 2 | 2022 | 809 | 0.070 |
Why?
|
Cell Adhesion | 2 | 2014 | 3144 | 0.070 |
Why?
|
Genotype | 3 | 2014 | 12951 | 0.070 |
Why?
|
Mice, Knockout | 4 | 2015 | 14557 | 0.070 |
Why?
|
Deoxyribonucleases, Type II Site-Specific | 1 | 2006 | 170 | 0.070 |
Why?
|
Matrix Metalloproteinase 13 | 1 | 2005 | 103 | 0.070 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2008 | 638 | 0.060 |
Why?
|
Collagenases | 1 | 2005 | 228 | 0.060 |
Why?
|
Calgranulin B | 1 | 2005 | 84 | 0.060 |
Why?
|
Quantitative Trait Loci | 1 | 2013 | 2019 | 0.060 |
Why?
|
Dioxygenases | 2 | 2009 | 316 | 0.060 |
Why?
|
Adult | 14 | 2021 | 214055 | 0.060 |
Why?
|
Epidermal Growth Factor | 1 | 2008 | 708 | 0.060 |
Why?
|
Maternal Exposure | 1 | 2012 | 961 | 0.060 |
Why?
|
Multicenter Studies as Topic | 1 | 2010 | 1677 | 0.060 |
Why?
|
Tumor Burden | 3 | 2015 | 1915 | 0.060 |
Why?
|
Phylogeny | 2 | 2002 | 2803 | 0.060 |
Why?
|
Muscle Cells | 1 | 2005 | 197 | 0.060 |
Why?
|
Age of Onset | 2 | 2002 | 3271 | 0.060 |
Why?
|
Substrate Specificity | 1 | 2008 | 1801 | 0.060 |
Why?
|
Polymerase Chain Reaction | 5 | 2009 | 6171 | 0.060 |
Why?
|
Cell Count | 1 | 2008 | 1856 | 0.060 |
Why?
|
Genetic Association Studies | 2 | 2013 | 2703 | 0.060 |
Why?
|
Aging | 1 | 2023 | 8664 | 0.060 |
Why?
|
Osteoclasts | 1 | 2008 | 729 | 0.060 |
Why?
|
Premenopause | 2 | 2020 | 1033 | 0.060 |
Why?
|
Algorithms | 5 | 2017 | 13881 | 0.060 |
Why?
|
Models, Genetic | 3 | 2011 | 3494 | 0.060 |
Why?
|
Sequence Alignment | 2 | 2001 | 2256 | 0.060 |
Why?
|
Genomic Instability | 1 | 2008 | 695 | 0.060 |
Why?
|
Chromosomal Instability | 1 | 2004 | 184 | 0.060 |
Why?
|
Mice, SCID | 4 | 2011 | 2716 | 0.060 |
Why?
|
Leukocytes | 1 | 2011 | 2043 | 0.060 |
Why?
|
RNA Interference | 3 | 2017 | 2889 | 0.060 |
Why?
|
Middle Aged | 13 | 2021 | 213383 | 0.060 |
Why?
|
Tissue Distribution | 3 | 2002 | 2327 | 0.060 |
Why?
|
Body Fluids | 1 | 2004 | 319 | 0.050 |
Why?
|
Growth Inhibitors | 2 | 2001 | 385 | 0.050 |
Why?
|
Microscopy, Atomic Force | 1 | 2023 | 250 | 0.050 |
Why?
|
Predictive Value of Tests | 2 | 2016 | 15076 | 0.050 |
Why?
|
Mitosis | 3 | 1997 | 1208 | 0.050 |
Why?
|
Uteroglobin | 1 | 2002 | 58 | 0.050 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2010 | 2015 | 0.050 |
Why?
|
Lymph Nodes | 1 | 2014 | 3474 | 0.050 |
Why?
|
Chemokine CXCL12 | 1 | 2004 | 464 | 0.050 |
Why?
|
Mice, Transgenic | 2 | 2012 | 9734 | 0.050 |
Why?
|
Mechanical Phenomena | 1 | 2023 | 140 | 0.050 |
Why?
|
DNA, Complementary | 1 | 2005 | 2050 | 0.050 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2022 | 1581 | 0.050 |
Why?
|
In Situ Hybridization | 2 | 2004 | 1950 | 0.050 |
Why?
|
Papillomavirus Infections | 1 | 2013 | 1587 | 0.050 |
Why?
|
Elasticity | 1 | 2023 | 657 | 0.050 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2013 | 2020 | 0.050 |
Why?
|
Subcellular Fractions | 1 | 2002 | 547 | 0.050 |
Why?
|
Response Elements | 1 | 2002 | 312 | 0.050 |
Why?
|
Penetrance | 1 | 2002 | 381 | 0.050 |
Why?
|
Esophageal Neoplasms | 1 | 2010 | 1583 | 0.050 |
Why?
|
DNA Mutational Analysis | 4 | 2012 | 4186 | 0.050 |
Why?
|
Autoantibodies | 1 | 2008 | 2035 | 0.050 |
Why?
|
Muscle, Smooth | 1 | 2004 | 934 | 0.050 |
Why?
|
Histidine | 1 | 2000 | 313 | 0.040 |
Why?
|
Combined Modality Therapy | 2 | 2010 | 8642 | 0.040 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2000 | 768 | 0.040 |
Why?
|
Oxidative Stress | 3 | 2017 | 3086 | 0.040 |
Why?
|
Leukemia | 1 | 2008 | 1511 | 0.040 |
Why?
|
Adenocarcinoma | 2 | 2010 | 6364 | 0.040 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2017 | 3597 | 0.040 |
Why?
|
Cricetulus | 1 | 2001 | 816 | 0.040 |
Why?
|
Luminescent Proteins | 1 | 2002 | 853 | 0.040 |
Why?
|
COS Cells | 1 | 2001 | 1161 | 0.040 |
Why?
|
Drug Delivery Systems | 2 | 2017 | 2219 | 0.040 |
Why?
|
Tretinoin | 1 | 2002 | 517 | 0.040 |
Why?
|
Spheroids, Cellular | 2 | 2013 | 351 | 0.040 |
Why?
|
Collagen | 2 | 2023 | 2689 | 0.040 |
Why?
|
Homeostasis | 2 | 2008 | 3340 | 0.040 |
Why?
|
Proteome | 1 | 2008 | 1799 | 0.040 |
Why?
|
CHO Cells | 1 | 2001 | 1406 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2005 | 1434 | 0.040 |
Why?
|
Cell Line, Transformed | 2 | 2011 | 898 | 0.040 |
Why?
|
Membrane Proteins | 3 | 2012 | 7880 | 0.040 |
Why?
|
Polyenes | 2 | 1994 | 69 | 0.040 |
Why?
|
Adenoviridae | 1 | 2002 | 1099 | 0.040 |
Why?
|
Bronchi | 1 | 2002 | 840 | 0.040 |
Why?
|
Ecological and Environmental Phenomena | 1 | 2017 | 12 | 0.040 |
Why?
|
Exonucleases | 1 | 1997 | 47 | 0.040 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2017 | 1692 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2021 | 57776 | 0.040 |
Why?
|
Age Factors | 1 | 2015 | 18370 | 0.040 |
Why?
|
Phosphofructokinase-1 | 1 | 2017 | 51 | 0.040 |
Why?
|
Cathepsin B | 1 | 2017 | 82 | 0.040 |
Why?
|
Reactive Nitrogen Species | 1 | 2017 | 35 | 0.040 |
Why?
|
G2 Phase | 1 | 1997 | 139 | 0.040 |
Why?
|
Cricetinae | 1 | 2001 | 2472 | 0.040 |
Why?
|
Pancreas | 1 | 2004 | 1686 | 0.040 |
Why?
|
Antioxidants | 1 | 2005 | 1663 | 0.040 |
Why?
|
Receptors, Cell Surface | 1 | 2007 | 2866 | 0.040 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2017 | 190 | 0.040 |
Why?
|
Pentose Phosphate Pathway | 1 | 2017 | 124 | 0.040 |
Why?
|
Cytoplasm | 1 | 2002 | 1539 | 0.040 |
Why?
|
Bone Marrow Cells | 1 | 2005 | 2513 | 0.040 |
Why?
|
Case-Control Studies | 3 | 2020 | 21746 | 0.040 |
Why?
|
Arginine | 1 | 2000 | 944 | 0.040 |
Why?
|
Acetaldehyde | 1 | 2016 | 39 | 0.040 |
Why?
|
Green Fluorescent Proteins | 1 | 2002 | 2088 | 0.040 |
Why?
|
Male | 11 | 2022 | 350118 | 0.040 |
Why?
|
Bone Marrow Transplantation | 1 | 2005 | 2765 | 0.040 |
Why?
|
Gigantism | 1 | 1996 | 15 | 0.040 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 1997 | 375 | 0.040 |
Why?
|
Alleles | 3 | 2007 | 6933 | 0.030 |
Why?
|
Medical Oncology | 1 | 2008 | 2265 | 0.030 |
Why?
|
Prostate | 1 | 2004 | 1774 | 0.030 |
Why?
|
Polyadenylation | 1 | 2016 | 117 | 0.030 |
Why?
|
DNA Primers | 3 | 2009 | 2892 | 0.030 |
Why?
|
Pyruvate Kinase | 1 | 2017 | 189 | 0.030 |
Why?
|
RNA, Satellite | 1 | 2014 | 17 | 0.030 |
Why?
|
3' Untranslated Regions | 1 | 2017 | 513 | 0.030 |
Why?
|
Time Factors | 5 | 2017 | 40075 | 0.030 |
Why?
|
Computational Biology | 3 | 2013 | 3521 | 0.030 |
Why?
|
Contact Inhibition | 1 | 1994 | 48 | 0.030 |
Why?
|
Gene Silencing | 1 | 2001 | 1538 | 0.030 |
Why?
|
Formaldehyde | 1 | 2016 | 353 | 0.030 |
Why?
|
Adenomatous Polyposis Coli | 1 | 1996 | 224 | 0.030 |
Why?
|
X Chromosome Inactivation | 1 | 2016 | 224 | 0.030 |
Why?
|
Mice, Inbred Strains | 1 | 2017 | 1827 | 0.030 |
Why?
|
Risk Assessment | 1 | 2016 | 23338 | 0.030 |
Why?
|
Rad51 Recombinase | 1 | 2014 | 189 | 0.030 |
Why?
|
Mitochondria | 2 | 2017 | 3520 | 0.030 |
Why?
|
Cyclin D2 | 2 | 2004 | 101 | 0.030 |
Why?
|
Methylation | 1 | 2017 | 1106 | 0.030 |
Why?
|
Purines | 1 | 2017 | 594 | 0.030 |
Why?
|
Internet | 2 | 2003 | 3064 | 0.030 |
Why?
|
Coculture Techniques | 1 | 2017 | 1341 | 0.030 |
Why?
|
Sequence Analysis | 1 | 1994 | 256 | 0.030 |
Why?
|
GATA3 Transcription Factor | 1 | 2014 | 157 | 0.030 |
Why?
|
Cytoskeletal Proteins | 1 | 1999 | 1364 | 0.030 |
Why?
|
Ovarian Neoplasms | 2 | 2008 | 4838 | 0.030 |
Why?
|
Protein Stability | 1 | 2015 | 557 | 0.030 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 1995 | 314 | 0.030 |
Why?
|
Aminopyridines | 1 | 2017 | 542 | 0.030 |
Why?
|
Serine | 1 | 2017 | 826 | 0.030 |
Why?
|
Chromosome Mapping | 2 | 2007 | 4740 | 0.030 |
Why?
|
Glycolysis | 1 | 2017 | 827 | 0.030 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 407 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2010 | 9959 | 0.030 |
Why?
|
Cloning, Molecular | 2 | 1999 | 4320 | 0.030 |
Why?
|
rac1 GTP-Binding Protein | 1 | 2014 | 237 | 0.030 |
Why?
|
Core Binding Factor beta Subunit | 1 | 2012 | 45 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 1 | 2001 | 3772 | 0.030 |
Why?
|
Lysine | 1 | 2017 | 1007 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 1995 | 705 | 0.030 |
Why?
|
Endothelial Cells | 1 | 2005 | 3479 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 1997 | 2187 | 0.030 |
Why?
|
Cell Transformation, Viral | 1 | 2013 | 565 | 0.030 |
Why?
|
Enzyme Inhibitors | 3 | 1997 | 3798 | 0.030 |
Why?
|
Interferon Type I | 1 | 2015 | 542 | 0.030 |
Why?
|
Steroids | 1 | 2017 | 930 | 0.030 |
Why?
|
Vietnam | 1 | 2012 | 408 | 0.020 |
Why?
|
Colonic Polyps | 1 | 1996 | 542 | 0.020 |
Why?
|
Adiposity | 1 | 2021 | 1807 | 0.020 |
Why?
|
Human papillomavirus 16 | 1 | 2013 | 262 | 0.020 |
Why?
|
Gene Expression Regulation, Viral | 1 | 2013 | 442 | 0.020 |
Why?
|
Cell Separation | 1 | 2017 | 1751 | 0.020 |
Why?
|
Glutathione | 1 | 2013 | 589 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 2017 | 1701 | 0.020 |
Why?
|
Microscopy, Phase-Contrast | 1 | 2010 | 115 | 0.020 |
Why?
|
Cyclic AMP | 1 | 1994 | 1472 | 0.020 |
Why?
|
Genetics | 1 | 2011 | 112 | 0.020 |
Why?
|
Nurses | 1 | 2020 | 2461 | 0.020 |
Why?
|
Transduction, Genetic | 1 | 2013 | 913 | 0.020 |
Why?
|
Mexico | 1 | 2012 | 690 | 0.020 |
Why?
|
GTPase-Activating Proteins | 1 | 2013 | 498 | 0.020 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2012 | 345 | 0.020 |
Why?
|
Cisplatin | 1 | 2016 | 1662 | 0.020 |
Why?
|
Infertility, Female | 1 | 1996 | 787 | 0.020 |
Why?
|
Chromogenic Compounds | 1 | 2009 | 30 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2015 | 987 | 0.020 |
Why?
|
Pancreatic Neoplasms | 2 | 2004 | 5256 | 0.020 |
Why?
|
Speech | 1 | 2014 | 540 | 0.020 |
Why?
|
Binding Sites | 2 | 2015 | 6114 | 0.020 |
Why?
|
Fluorescent Antibody Technique, Direct | 1 | 2009 | 69 | 0.020 |
Why?
|
Trans-Activators | 1 | 1999 | 2924 | 0.020 |
Why?
|
Cancer Vaccines | 1 | 2017 | 1023 | 0.020 |
Why?
|
Research Report | 1 | 2012 | 355 | 0.020 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2017 | 1222 | 0.020 |
Why?
|
Gene Fusion | 1 | 2012 | 371 | 0.020 |
Why?
|
Benchmarking | 1 | 2015 | 1042 | 0.020 |
Why?
|
Models, Theoretical | 2 | 2017 | 3589 | 0.020 |
Why?
|
Ultraviolet Therapy | 1 | 2008 | 81 | 0.020 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2010 | 563 | 0.020 |
Why?
|
Mucin-1 | 1 | 2012 | 543 | 0.020 |
Why?
|
Microtubules | 1 | 2014 | 1090 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2010 | 39050 | 0.020 |
Why?
|
Receptor, IGF Type 1 | 1 | 2010 | 390 | 0.020 |
Why?
|
Microdissection | 1 | 2008 | 152 | 0.020 |
Why?
|
Heterozygote | 1 | 2014 | 2804 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2018 | 6895 | 0.020 |
Why?
|
Codon | 1 | 2009 | 611 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2010 | 905 | 0.020 |
Why?
|
Quantum Dots | 1 | 2009 | 172 | 0.020 |
Why?
|
Fibrocystic Breast Disease | 1 | 2008 | 102 | 0.020 |
Why?
|
Interleukin-2 | 1 | 1994 | 1904 | 0.020 |
Why?
|
Pituitary Neoplasms | 1 | 1996 | 1345 | 0.020 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2008 | 351 | 0.020 |
Why?
|
Paraffin Embedding | 1 | 2008 | 299 | 0.020 |
Why?
|
Chemokine CCL5 | 1 | 2007 | 209 | 0.020 |
Why?
|
Internationality | 1 | 2012 | 1003 | 0.020 |
Why?
|
Cohort Studies | 1 | 2010 | 40561 | 0.020 |
Why?
|
Connective Tissue | 1 | 2009 | 420 | 0.020 |
Why?
|
Chemokines, CC | 1 | 2007 | 291 | 0.020 |
Why?
|
Genome | 2 | 2007 | 1808 | 0.020 |
Why?
|
Laminin | 1 | 2008 | 419 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2016 | 2716 | 0.020 |
Why?
|
Adipocytes | 1 | 2013 | 1184 | 0.020 |
Why?
|
Osteolysis | 1 | 2008 | 270 | 0.020 |
Why?
|
Reference Values | 2 | 2003 | 4982 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2010 | 2915 | 0.020 |
Why?
|
Receptors, CCR5 | 1 | 2007 | 497 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 1996 | 3036 | 0.020 |
Why?
|
Interleukin-8 | 1 | 2008 | 690 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2010 | 14722 | 0.020 |
Why?
|
Proteoglycans | 1 | 2008 | 835 | 0.020 |
Why?
|
Risk | 1 | 2017 | 9687 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 625 | 0.020 |
Why?
|
Drug Discovery | 1 | 2012 | 1058 | 0.020 |
Why?
|
Databases, Factual | 1 | 1999 | 7729 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2010 | 1970 | 0.020 |
Why?
|
Acetylcysteine | 1 | 2005 | 272 | 0.010 |
Why?
|
Survival Rate | 1 | 2018 | 12788 | 0.010 |
Why?
|
Chromosomes, Human, Y | 1 | 2005 | 148 | 0.010 |
Why?
|
Adolescent | 2 | 2021 | 85781 | 0.010 |
Why?
|
Tyrosine | 1 | 2008 | 1461 | 0.010 |
Why?
|
Consensus | 1 | 2012 | 2959 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2017 | 4042 | 0.010 |
Why?
|
Chromosomes, Human, X | 1 | 2005 | 296 | 0.010 |
Why?
|
HeLa Cells | 1 | 2009 | 3128 | 0.010 |
Why?
|
Metabolic Networks and Pathways | 1 | 2007 | 783 | 0.010 |
Why?
|
Gene Deletion | 1 | 2011 | 2751 | 0.010 |
Why?
|
Mammaplasty | 1 | 2013 | 1204 | 0.010 |
Why?
|
Software | 2 | 2007 | 4443 | 0.010 |
Why?
|
DNA | 1 | 2017 | 7301 | 0.010 |
Why?
|
Drug Combinations | 1 | 2008 | 1959 | 0.010 |
Why?
|
Bayes Theorem | 1 | 2010 | 2309 | 0.010 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2007 | 496 | 0.010 |
Why?
|
Stem Cell Transplantation | 1 | 2011 | 1620 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2009 | 1678 | 0.010 |
Why?
|
Mice, Inbred C57BL | 2 | 2017 | 21827 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2010 | 6365 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 1994 | 4149 | 0.010 |
Why?
|
Survival Analysis | 1 | 2014 | 10252 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2004 | 11124 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 3870 | 0.010 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2010 | 2109 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2007 | 2373 | 0.010 |
Why?
|
Multigene Family | 1 | 2003 | 1102 | 0.010 |
Why?
|
Colonic Neoplasms | 2 | 2003 | 2541 | 0.010 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2009 | 2043 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2010 | 6538 | 0.010 |
Why?
|
Genetics, Medical | 1 | 2002 | 338 | 0.010 |
Why?
|
Artifacts | 1 | 2008 | 1904 | 0.010 |
Why?
|
Obesity | 1 | 2021 | 12745 | 0.010 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 1999 | 188 | 0.010 |
Why?
|
DNA, Satellite | 1 | 1998 | 69 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2000 | 380 | 0.010 |
Why?
|
Polyploidy | 1 | 1997 | 114 | 0.010 |
Why?
|
Exoribonucleases | 1 | 1997 | 95 | 0.010 |
Why?
|
Sirolimus | 2 | 1994 | 1564 | 0.010 |
Why?
|
14-3-3 Proteins | 1 | 1997 | 214 | 0.010 |
Why?
|
Thymus Hyperplasia | 1 | 1996 | 30 | 0.010 |
Why?
|
Eukaryotic Cells | 1 | 1997 | 198 | 0.010 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p15 | 1 | 1995 | 65 | 0.010 |
Why?
|
Mastectomy | 1 | 2004 | 1793 | 0.010 |
Why?
|
MutS Homolog 2 Protein | 1 | 1996 | 200 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2012 | 7279 | 0.010 |
Why?
|
Young Adult | 1 | 2021 | 56430 | 0.010 |
Why?
|
Threonine | 1 | 1995 | 279 | 0.010 |
Why?
|
Glioma | 1 | 2009 | 3401 | 0.010 |
Why?
|
Peptide Mapping | 1 | 1994 | 263 | 0.010 |
Why?
|
beta Catenin | 1 | 1999 | 1059 | 0.010 |
Why?
|
Regression Analysis | 1 | 2004 | 6459 | 0.010 |
Why?
|
Allosteric Regulation | 1 | 1995 | 408 | 0.010 |
Why?
|
Precipitin Tests | 1 | 1994 | 829 | 0.010 |
Why?
|
Computer Graphics | 1 | 1995 | 361 | 0.010 |
Why?
|
Child | 1 | 2021 | 77709 | 0.010 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 1995 | 491 | 0.010 |
Why?
|
Mammography | 1 | 2004 | 2476 | 0.010 |
Why?
|
Cell Extracts | 1 | 1993 | 138 | 0.010 |
Why?
|
Antigen-Antibody Complex | 1 | 1994 | 517 | 0.010 |
Why?
|
Gene Targeting | 1 | 1996 | 880 | 0.010 |
Why?
|
Protein Folding | 1 | 1995 | 843 | 0.010 |
Why?
|
Bone Neoplasms | 1 | 2004 | 2529 | 0.010 |
Why?
|
United States | 2 | 2012 | 69872 | 0.010 |
Why?
|
Crystallography, X-Ray | 1 | 1995 | 2011 | 0.010 |
Why?
|
Syndrome | 1 | 1996 | 3251 | 0.010 |
Why?
|
Esophagus | 1 | 1996 | 1019 | 0.010 |
Why?
|
Adenosine Triphosphate | 1 | 1995 | 2025 | 0.010 |
Why?
|
Colon | 1 | 1996 | 1772 | 0.000 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 1998 | 2916 | 0.000 |
Why?
|
Protein Conformation | 1 | 1995 | 4011 | 0.000 |
Why?
|
Prevalence | 1 | 2004 | 15226 | 0.000 |
Why?
|
Mice, Inbred BALB C | 1 | 1996 | 6386 | 0.000 |
Why?
|
Recombinant Proteins | 1 | 1995 | 6622 | 0.000 |
Why?
|
Adenoma | 1 | 1996 | 2174 | 0.000 |
Why?
|
Lymphocyte Activation | 1 | 1996 | 5524 | 0.000 |
Why?
|
Glioblastoma | 1 | 1999 | 3481 | 0.000 |
Why?
|
Escherichia coli | 1 | 1995 | 4217 | 0.000 |
Why?
|
Antibodies, Monoclonal | 1 | 1996 | 9274 | 0.000 |
Why?
|
Brain | 1 | 1999 | 26385 | 0.000 |
Why?
|